The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
It is this size and broad global footprint that enables Accord to manufacture and deliver vital, affordable medicines to healthcare providers and patients in over 85 countries around the world. The company’s rapidly expanding product portfolio now comprises over 8,500 approved products spanning critical therapeutic fields such as oncology, cardiology, neurology, psychiatry, diabetes, pain management and gastroenterology.